Increased serum levels of lipogenic enzymes in patients with severe liver steatosis

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Notarnicola, Maria ^a   Misciagna, Giovanni ^a   Tutino, Valeria ^a   Chiloiro, Marisa ^a   Osella, Alberto Ruben ^a   Guerra, Vito ^a   Bonfiglio, Caterina ^a   Caruso, Maria Gabriella ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Enzyme activity; Fatty acid synthase; Lipoprotein lipase; Liver steatosis

Indexed keywords

FAS ANTIGEN; LIPOPROTEIN LIPASE;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; WILCOXON SIGNED RANKS TEST;

ADULT; AGED; BIOLOGICAL MARKERS; FATTY ACID SYNTHETASE COMPLEX, TYPE I; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED;

EID: 84867900806     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-145     Document Type: Article

References (30)

1. Liver fibrogenesis and metabolic factors. Anty R, Lemoine M, Clinics and Research in Hepatology and Gastroenterology 2001 35 10 S20
2. Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Fernandez-Real JM, Menendez JA, Moreno-Navarrete JM, Blüher M, Vazquez-Martin A, Vázquez MJ, Ortega F, Diéguez C, Frühbeck G, Ricart W, Vidal-Puig A, Diabetes 2010 59 1506 1511 10.2337/db09-1756 20299470
3. Regulation of fatty acid synthase (FAS). Semenkovich CF, Prog Lipid Res 1997 36 43 53 10.1016/S0163-7827(97)00003-9 9373620 (Pubitemid 27387114)
4. Expression of fatty acid synthase in nonalcoholic fatty liver disease. Dorn C, Riener MO, Kirovski G, Saugspier M, Steib K, Weiss TS, Gäbele E, Kristiansen G, Hartmann A, Hellerbrand C, Int J Clin Exp Pathol 2010 3 505 514 20606731
5. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Menendez JA, Lupu R, Nat Rev Cancer 2007 7 763 777 10.1038/nrc2222 17882277 (Pubitemid 47469806)
6. AMPK-sensed cellular energy state regulates the release of extracellular fatty acid synthase. Oliveras-Ferraros C, Vazquez-Martin A, Fernandez-Real JM, Menendez JA, Biochem Biophys Res Commun 2009 378 488 493 10.1016/j.bbrc.2008.11. 067 19032940
7. Fatty acid synthase expression in human breast cancer cell culture supernatants and in breast cancer patients. Wang Y, Kuhajda FP, Li JN, Pizer ES, Han WF, Sokoll LJ, Chan DW, Cancer Lett 2001 167 99 104 10.1016/S0304-3835(01) 00464-5 11323104 (Pubitemid 32373274)
8. Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Vazquez-Martin A, Fernandez-Real JM, Oliveras-Ferraros C, Navarrete JM, Martin-Castillo B, Del Barco S, Brunet J, Menendez JA, Int J Oncology 2009 35 1369 1376
9. Serum levels of Fatty Acid Synthase in colorectal cancer patients are associated with tumor stage. Notarnicola M, Tutino V, Calvani M, Lorusso D, Guerra V, Caruso MG, J Gastrointestinal Cancer 2011 31 3381 3383
10. Serum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosis. Joven J, Espinel E, Rull A, Beltrán-Debón R, Aragonès G, Rodríguez-Gallego E, Camps J, Pedro-Botet J, Sans T, Menéndez JA, Alonso-Villaverde C, J Clinical Virology 2011 51 199 201 10.1016/j.jcv.2011.04. 003
11. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Mashima T, Seimiya H, Tsuruo T, Br J Cancer 2009 100 1369 1372 10.1038/sj.bjc.6605007 19352381
12. Cohort study of fatty acid synthase expression and patient survival in colon cancer. Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, Giovannucci EL, Loda M, Fuchs CS, J Clin Oncol 2008 26 5713 5720 10.1200/JCO.2008.18.2675 18955444
13. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. Notarnicola M, Altomare DF, Calvani M, Orlando A, Bifulco M, D'Attoma B, Caruso MG, Oncology 2006 71 327 332 10.1159/000107106 17687193 (Pubitemid 47573693)
14. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. Eckel RH, N Engl J Med 1989 320 1060 1068 10.1056/NEJM198904203201607 2648155 (Pubitemid 19105751)
15. Lipoprotein lipase steady-state NmRNA levels are lower in human omental versus subcutaneous abdominal adipose tissue. Panarotto D, Poisson J, Devroede G, Maheux P, Metabolism 2000 49 1224 1227 10.1053/meta.2000.8624 11016909
16. Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival. Trost Z, Sok M, Marc J, Cerne D, Archives of Medical Res 2009 40 364 368 10.1016/j.arcmed.2009.05.001
17. Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients. Notarnicola M, Miccolis A, Tutino V, Lorusso D, Caruso MG, Lipids 2012 47 59 63 10.1007/s11745-011-3630-5 22090062
18. High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis. Ahn J, Lee H, Chung CH, Ha T, Biochem Biophys Res Commun 2001 414 664 669
19. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y, Dig Dis Sci 1995 40 2002 2009 10.1007/BF02208670 7555456
20. Relationship among fatty liver, adipose tissue distribution and metabolic profile in moderately obese children: an ultrasonographic study. Chiloiro M, Riezzo G, Chiarappa S, Correale M, Guerra V, Amati L, Noviello MR, Jirillo E, Curr Pharm Des 2008 14 2693 2698 10.2174/138161208786264197 18991688
21. Serum α-fetoprotein levels in liver steatosis. Babali A, Cakal E, Purnak T, Bykolu I, Cakal B, Yüksel O, Köklü S, Hepatol Int 2009 3 551 555 10.1007/s12072-009-9156-8 19890679
22. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T, Am J Gastroenterol 2007 12 2708 2715 (Pubitemid 350179336)
23. Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery. Liang RJ, Wang HH, Lee WJ, Liew PL, Lin JT, Wu MS, Obese Surg 2007 17 45 56 10.1007/s11695-007-9005-6
24. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Mishra P, Younossi ZM, Am J Gastroenterol 2007 102 2716 2717 10.1111/j.1572-0241.2007.01520.x 18042105 (Pubitemid 350179334)
25. Obesity, fatty acid synthase and cancer serendipidy or forgotten causal linkage? Menendez JA, Lupu R, Colomer R, Mol Genet Metab 2005 84 293 295 10.1016/j.ymgme.2004.10.007 15694180 (Pubitemid 40207441)
26. Lipoprotein lipase: structure, function, regulation and role in disease. Mead JR, Irvine SA, Ramji DP, J Mol Med 2002 80 753 769 10.1007/s00109-002-0384- 9 12483461 (Pubitemid 35478124)
27. Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats. Lanza-Jacoby S, Lansey SC, Miller EE, Cleary MP, Cancer Res 1984 44 5062 5067 6386147 (Pubitemid 15204464)
28. Is there a relationship between the kinetics of lipoprotein lipase activity after a meal and the susceptibility to hepatic steatosis development in ducks? Saez G, Baeza E, Bernadet MD, Davail S, Poult Sci 2010 89 2453 2460 10.3382/ps.2010-00683 20952709
29. Definition of metabolic syndrome: Report of National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C, Circulation 2004 109 433 438 10.1161/01.CIR.0000111245.75752.C6 14744958 (Pubitemid 38133916)
30. Association of non-alcoholic fatty liver disease with insulin resistance. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N, Am J Med 1999 107 450 455 10.1016/S0002-9343(99) 00271-5 10569299 (Pubitemid 29528333)